Smackdown: Immune vs Targeted Tx in Rare Kidney Cancers


<![CDATA[]]>(MedPage Today) — MIAMI — If you’re treating a patient with advanced non-clear cell renal cell carcinoma (RCC) on Monday and grappling with whether to grab an immunotherapy or choose… Source link